查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1422819

2024-2032 年聚乙二醇化蛋白质市场报告（按产品、蛋白质类型、应用、最终用户和地区）

PEGylated Proteins Market Report by Product, Protein Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3个工作天内

价格

2023年全球聚乙二醇化蛋白市场规模达13亿美元。展望未来， IMARC Group预计到2032年市场规模将达到28亿美元，2024-2032年复合年增长率（CAGR）为8.87%。慢性病盛行率的增加、癌症治疗中产品的广泛使用以及聚乙二醇化蛋白产品批准数量的不断增加是推动市场发展的一些关键因素。

聚乙二醇化蛋白质是透过与聚乙二醇 (PEG) 共价结合进行修饰的生物分子。它涉及聚乙二醇化技术，透过改变生物分子的物理和化学特性（例如其构象、静电结合和疏水性）来改善药物的药物动力学行为。聚乙二醇化蛋白广泛用于治疗应用，例如疫苗、荷尔蒙替代疗法、遗传性疾病、贫血和凝血障碍。它也用于治疗多种疾病的药物，包括肾臟病、多发性硬化症、血友病和癌症。聚乙二醇化蛋白质有助于延长半衰期，增加稳定性、溶解度和蛋白水解保护，减少肾臟排泄、免疫原性和毒性，并增强药物传递的功效。除此之外，聚乙二醇化蛋白质无毒性、水溶性、亲水性、非抗原性和非免疫原性。

聚乙二醇化蛋白质市场趋势：

全球肾臟疾病、自体免疫疾病、遗传性疾病、肝炎和类风湿性关节炎等慢性病盛行率的上升是推动市场成长的关键因素之一。聚乙二醇化蛋白广泛用于治疗发炎、向细胞传递校正基因、预防血栓、传递生长激素、预防慢性肾臟病的进展。与此一致的是，在癌症治疗中广泛使用产品将化疗药物直接输送到癌细胞并减少对健康细胞的副作用，有利于市场成长。除此之外，聚乙二醇化技术的各种改进，例如开发可以生产更小和更复杂分子的新聚乙二醇化方法，正在为市场成长提供动力。此外，广泛采用聚乙二醇化来提高集落刺激因子 (CSF) 的稳定性和半衰期，使它们作为治疗剂更有效，这也是另一种生长诱导因子。此外，与非蛋白质药物相比，蛋白质药物的采用率不断上升，其中聚乙二醇化增加了蛋白质的循环和半衰期，提高了其效率，正在推动市场成长。其他因素，包括聚乙二醇化蛋白产品批准数量的增加、生物技术和分子生物学工程领域的发展、聚乙二醇分子在生物製药中的整合及其相关优势、老年人口的增加以及各种政府倡议的实施製药业的监管标准预计将推动市场进一步成长。

本报告回答的关键问题

  • 全球聚乙二醇化蛋白市场有多大？
  • 2024-2032年全球聚乙二醇化蛋白市场的预期成长率是多少？
  • 推动全球聚乙二醇化蛋白质市场的关键因素是什么？
  • COVID-19 对全球聚乙二醇化蛋白市场有何影响？
  • 基于该产品的全球聚乙二醇化蛋白市场的细分情况如何？
  • 根据蛋白质类型，全球聚乙二醇化蛋白质市场的细分情况如何？
  • 根据应用，全球聚乙二醇化蛋白市场的细分情况如何？
  • 根据最终用户，全球聚乙二醇化蛋白质市场的细分情况如何？
  • 全球聚乙二醇化蛋白市场的关键区域有哪些？
  • 谁是全球聚乙二醇化蛋白质市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球聚乙二醇化蛋白市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 耗材
    • 市场走向
    • 关键环节
      • 聚乙二醇化试剂
      • 聚乙二醇化试剂盒
    • 市场预测
  • 服务
    • 市场走向
    • 市场预测

第 7 章：市场细分：按蛋白质类型

  • 集落刺激因子
    • 市场走向
    • 市场预测
  • 干扰素
    • 市场走向
    • 市场预测
  • 促红血球生成素
    • 市场走向
    • 市场预测
  • 单株抗体
    • 市场走向
    • 市场预测
  • 重组因子VII
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按应用

  • 癌症治疗
    • 市场走向
    • 市场预测
  • 肝炎
    • 市场走向
    • 市场预测
  • 慢性肾臟病
    • 市场走向
    • 市场预测
  • 血友病
    • 市场走向
    • 市场预测
  • 多发性硬化症
    • 市场走向
    • 市场预测
  • 胃肠道疾病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 製药和生物技术公司
    • 市场走向
    • 市场预测
  • 合约研究组织
    • 市场走向
    • 市场预测
  • 学术及研究机构
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abcam plc
    • Biomatrik Inc.
    • Creative PEGWorks
    • Iris Biotech GmbH
    • JenKem Technology USA Inc.
    • Laysan Bio Inc.
    • NOF America Corporation (NOF Corporation)
    • Profacgen
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A7070

Abstract

The global PEGylated proteins market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 8.87% during 2024-2032. The increasing prevalence of chronic diseases, the widespread product utilization in cancer treatment, and the escalating number of product approvals for PEGylated proteins represent some of the key factors driving the market.

PEGylated proteins are biomolecules that have been modified by covalent conjugation with polyethylene glycol (PEG). It involves the PEGylation technique that improves the pharmacokinetic behavior of the medicine by altering the biological molecule's physical and chemical characteristics, such as its conformation, electrostatic binding, and hydrophobicity. PEGylated proteins are widely used in therapeutic applications, such as vaccines, hormone replacement therapy, genetic disorders, anemia, and blood clotting disorder. It is also used in various drugs for diseases, including kidney disease, multiple sclerosis, hemophilia, and cancers. PEGylated proteins help in the extension of half-life, increasing stability, solubility, and proteolytic protection, reducing renal excretion, immunogenicity, and toxicity, and enhancing the efficacy of drug delivery. Besides this, PEGylated proteins are non-toxic, water-soluble, hydrophilic, non-antigenic, and non-immunogenic.

PEGylated Proteins Market Trends:

The rising prevalence of chronic diseases, such as kidney ailments, autoimmune diseases, genetic disorders, hepatitis, and rheumatoid arthritis across the globe is one of the key factors driving the market growth. PEGylated proteins are widely used to treat inflammation, deliver corrective genes to cells, prevent blood clots, deliver growth hormones, and prevent the progression of chronic kidney disease. In line with this, the widespread product utilization in cancer treatment to deliver chemotherapy drugs directly to cancer cells and reduce the side effects on healthy cells is favoring the market growth. Apart from this, various improvements in the PEGylation technology, such as the development of new PEGylation methods that can produce smaller and more complex molecules, are providing an impetus to the market growth. Additionally, the widespread adoption of PEGylation to improve the stability and half-life of colony-stimulating factors (CSFs), making them more effective as therapeutic agents, is acting as another growth-inducing factor. Furthermore, the rising adoption of protein-based drugs over non-protein-based drugs wherein PEGylation increases the circulation and half-life of the proteins, improving its efficiency, is propelling the market growth. Other factors, including the increasing number of product approvals for PEGylated proteins, development in the field of biotechnology and molecular biology engineering, the integration of PEG molecules in biopharmaceuticals and the associated advantages, rising geriatric population, and the implementation of various government initiatives to increase regulatory standards in the pharmaceutical industry, are anticipated drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global PEGylated proteins market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, protein type, application, and end user.

Product Insights:

Consumables

PEGylation Reagents

PEGylation Kits

Services

A detailed breakup and analysis of the PEGylated proteins market based on the product has also been provided in the report. This includes consumables (PEgylation reagents and PEgylation kits) and services. According to the report, consumables accounted for the largest market share.

Protein Type Insights:

Colony Stimulating Factors

Interferons

Erythropoietin

mAbs

Recombinant Factor VII

Others

The report has provided a detailed breakup and analysis of the PEGylated proteins market based on the protein type. This includes colony stimulating factors, interferons, erythropoietin, mAbs, recombinant factor VII and others. According to the report, colony stimulating factors represented the largest segment.

Application Insights:

Cancer Treatment

Hepatitis

Chronic Kidney Diseases

Hemophilia

Multiple Sclerosis

Gastrointestinal Disorders

Others

A detailed breakup and analysis of the PEGylated proteins market based on the application has also been provided in the report. This includes cancer treatment, hepatitis, chronic kidney diseases, hemophilia, multiple sclerosis, gastrointestinal disorders, and others. According to the report, cancer treatment represented the largest segment.

End User Insights:

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Academic and Research Institutes

The report has provided a detailed breakup and analysis of the PEGylated proteins market based on the end user. This includes pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes. According to the report, pharmaceutical and biotechnology companies represented the largest segment.

Regional Insights:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for PEGylated proteins. Some of the factors driving the North America PEGylated proteins market included the rising geriatric population, increasing prevalence of chronic diseases, and extensive research and development (R&D).

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global PEGylated proteins market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abcam plc, Biomatrik Inc., Creative PEGWorks, Iris Biotech GmbH, JenKem Technology USA Inc., Laysan Bio Inc., NOF America Corporation (NOF Corporation), Profacgen, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report

  • 1. How big is the global PEGylated proteins market?
  • 2. What is the expected growth rate of the global PEGylated proteins market during 2024-2032?
  • 3. What are the key factors driving the global PEGylated proteins market?
  • 4. What has been the impact of COVID-19 on the global PEGylated proteins market?
  • 5. What is the breakup of the global PEGylated proteins market based on the product?
  • 6. What is the breakup of the global PEGylated proteins market based on the protein type?
  • 7. What is the breakup of the global PEGylated proteins market based on the application?
  • 8. What is the breakup of the global PEGylated proteins market based on the end user?
  • 9. What are the key regions in the global PEGylated proteins market?
  • 10. Who are the key players/companies in the global PEGylated proteins market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global PEGylated Proteins Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 PEGylation Reagents
      • 6.1.2.2 PEGylation Kits
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Protein Type

  • 7.1 Colony Stimulating Factors
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Interferons
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Erythropoietin
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 mAbs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Recombinant Factor VII
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Cancer Treatment
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hepatitis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Chronic Kidney Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Hemophilia
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Multiple Sclerosis
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Gastrointestinal Disorders
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Contract Research Organizations
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abcam plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Biomatrik Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Creative PEGWorks
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Iris Biotech GmbH
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 JenKem Technology USA Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Laysan Bio Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 NOF America Corporation (NOF Corporation)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Profacgen
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Thermo Fisher Scientific Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: PEGylated Proteins Market: Major Drivers and Challenges
  • Figure 2: Global: PEGylated Proteins Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: PEGylated Proteins Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: PEGylated Proteins Market: Breakup by Product (in %), 2023
  • Figure 5: Global: PEGylated Proteins Market: Breakup by Protein Type (in %), 2023
  • Figure 6: Global: PEGylated Proteins Market: Breakup by Application (in %), 2023
  • Figure 7: Global: PEGylated Proteins Market: Breakup by End User (in %), 2023
  • Figure 8: Global: PEGylated Proteins Market: Breakup by Region (in %), 2023
  • Figure 9: Global: PEGylated Proteins (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: PEGylated Proteins (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: PEGylated Proteins (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: PEGylated Proteins (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: PEGylated Proteins (Colony Stimulating Factors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: PEGylated Proteins (Colony Stimulating Factors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: PEGylated Proteins (Interferons) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: PEGylated Proteins (Interferons) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: PEGylated Proteins (Erythropoietin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: PEGylated Proteins (Erythropoietin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: PEGylated Proteins (mAbs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: PEGylated Proteins (mAbs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: PEGylated Proteins (Recombinant Factor VII) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: PEGylated Proteins (Recombinant Factor VII) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: PEGylated Proteins (Other Protein Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: PEGylated Proteins (Other Protein Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: PEGylated Proteins (Cancer Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: PEGylated Proteins (Cancer Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: PEGylated Proteins (Hepatitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: PEGylated Proteins (Hepatitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: PEGylated Proteins (Chronic Kidney Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: PEGylated Proteins (Chronic Kidney Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: PEGylated Proteins (Hemophilia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: PEGylated Proteins (Hemophilia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: PEGylated Proteins (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: PEGylated Proteins (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: PEGylated Proteins (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: PEGylated Proteins (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: PEGylated Proteins (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: PEGylated Proteins (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: PEGylated Proteins (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: PEGylated Proteins (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: PEGylated Proteins (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: PEGylated Proteins (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: North America: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: North America: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United States: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United States: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Canada: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Canada: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Asia-Pacific: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Asia-Pacific: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: China: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: China: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Japan: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Japan: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: India: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: India: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: South Korea: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: South Korea: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Australia: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Australia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Indonesia: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Indonesia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Europe: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Europe: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Germany: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Germany: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: France: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: France: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: United Kingdom: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: United Kingdom: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Italy: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Italy: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Spain: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Spain: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Russia: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Russia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Latin America: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Latin America: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Brazil: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Brazil: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Mexico: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Mexico: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Middle East and Africa: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Middle East and Africa: PEGylated Proteins Market: Breakup by Country (in %), 2023
  • Figure 93: Middle East and Africa: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 94: Global: PEGylated Proteins Industry: Drivers, Restraints, and Opportunities
  • Figure 95: Global: PEGylated Proteins Industry: Value Chain Analysis
  • Figure 96: Global: PEGylated Proteins Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: PEGylated Proteins Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: PEGylated Proteins Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: PEGylated Proteins Market Forecast: Breakup by Protein Type (in Million US$), 2024-2032
  • Table 4: Global: PEGylated Proteins Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: PEGylated Proteins Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: PEGylated Proteins Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: PEGylated Proteins Market: Competitive Structure
  • Table 8: Global: PEGylated Proteins Market: Key Players